Recombinant Human TNFSF13B Protein，His

TNFSF13B, also known as B-cell activating factor (BAFF), is a member of the tumor necrosis factor (TNF) superfamily that plays a crucial role in the regulation of B cell survival, differentiation, and maturation. Its importance in immune responses has led to significant interest in understanding its biological functions and mechanisms of action. Dysregulation of TNFSF13B has been implicated in various autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis, making it a potential therapeutic target. Research on recombinant TNFSF13B protein aims to elucidate its structural and functional properties, assess its role in B cell dynamics, and explore its potential applications in disease treatment. Studies have shown that manipulating TNFSF13B levels can influence the proliferation of B cells and the production of immunoglobulins, highlighting its pivotal role in adaptive immunity. Additionally, recombinant forms of TNFSF13B are being investigated for their potential in developing new therapies for immune-related conditions, as well as in enhancing vaccine responses. Understanding the detailed interactions of TNFSF13B with its receptors and other signaling pathways is essential for designing effective interventions that can modulate immune responses in both autoimmune disorders and clinical settings. Thus, continued research on TNFSF13B recombinant protein holds promise for advancing our knowledge of immune regulation and improving therapeutic strategies in immunology.